Rice University scientists have refined specific CRISPR-base editing strategies to avoid errors that occur during gene editing.
List view / Grid view
Victoria Rees (Drug Target Review)
A new label-free technique has been developed for molecularly specific exosome biosensing in diagnostics and biomarker detection.
Researchers have shown that a new microneedle vaccine patch was 10 times stronger at generating an immune response in animals than a subcutaneous injection.
A new antiviral has shown promise against the dengue virus in mice and has the potential to be used as a preventative measure.
Research from Yale University has shown that psilocybin, given to mice, triggered an increase in connections between neurons.
In a new study, researchers at Brigham and Women’s Hospital, US, successfully developed stem cell-derived neuronal profiles from individual patients. Here, Drug Target Review’s Victoria Rees explores the findings and how these new models can help to advance precision and personalised medicine.
Dr Ronald G Crystal, Professor and Chairman of the Department of Genetic Medicine, Weill Cornell Medical College, spoke to Drug Target Review’s Victoria Rees about his research into Alzheimer’s disease and why gene therapies represent a promising area of research for neurodegenerative conditions.
Researchers have identified a process that amplifies changes in gene expression, which could be harnessed to accelerate stem cell differentiation.
Researchers have published a step-by-step protocol on how to produce millions of mature human cells in a chimeric mouse embryo.
In brain tissues, researchers have shown that two different nanosized polyoxoniobate molecules can inhibit the assembly of amyloid plaques.
Using deep machine learning, researchers have completed the activity profiles, from chemistry to clinical level, for one million molecules.
Researchers have shown that natural killer cell immunotherapy effectively treated mice harbouring human melanoma tumours.
Following a whole exome sequencing study, researchers have found that mutations in the SLITRK5 gene could be targeted by drugs to treat OCD.
Researchers have designed an antibody that attaches to MuSK, which prevented early lethality of mice with congenital myasthenia.
A study has uncovered previously unknown properties of the Spike protein from the SARS-CoV-2 Alpha and Beta variants.